Chemomab Therapeutics Ltd. CMMB
1.14 USD -0.41 (-26.45%)
Regular-session close
1.14 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
1.10 Day range 1.58
0.92 52-week range 2.99
- YTD
- -30.91%
- 1 year
- -57.78%
News
benzinga.com Chemomab Therapeutics Q3 EPS $(0.63) Misses $(0.12) Estimate Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.12) by 472.73 percent. This is a 96.88 percent decrease over…
globenewswire.com Chemomab Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update Proposed merger with Scipher Medicine with plans to assess nebokitug in a Phase 2 precision medicine trial in rheumatoid arthritis (RA) continues to advance, with closing expected in the first…
